Clinical trial NCT05260944: Power Lung Versus Acapella After Coronary Artery Bypass Graft Surgery
Official title: Power Lung Versus Acapella on Airway Clearance After Coronary Artery Bypass Graft Surgery
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Coronary Artery Bypass Graft Surgery
Lead sponsor: South Valley University
Sponsor class: OTHER
First posted: 2022-03-02
Enrollment: 90
Sex: ALL
Minimum age (years): 40
Maximum age (years): 50
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: In the study three groups of patients will participated first, group A. Will receive acapella device.

Second, group B. Will receive power lung device. Third, group C. Will receive only routine physical Therapy program.
Primary purpose: PREVENTION

Brief summary: The purpose of the study is to compare between the power lung versus acapella on airway clearance after coronary artery bypass graft surgery.

Detailed description: In this part of the study the materials and methods will be presented under the following headings: subjects, equipments, procedures of the study and statistical procedures

1. Subjects. Ninty patients of both sexes will participate in this study with an age range of 40 to 50 years old. They will be chosen from outpatient clinic, Qena University Hospital.

   Patients will be randomely assigned into three groups:

   Group A: patients will receive a two supervised sessions using acapella device three sets for 10 repetitions from the first day postoperative until 7 days, in addition to routine physiotherapy program (phase I cardiac rehabilitation, breathing exercises, postural drainage, percussion and vibration.

   Group B: patients will receive a two supervised session using power lung device three sets for 10 repetitions two times daily from first day postoperative until 7 days, in addition to routine physiotherapy program (phase I cardiac rehabilitation, breathing exercises, postural drainage, Percussion and vibration).

   Group C. Patients will receive only routine physical Therapy program.
2. Equipment:

1. For evaluation: Arterial blood gases including: - paO2, paCO2, PH and O2 saturation. Spirometry measurements: - as forced vital capacity (FVC) andbforced expiratory volume in the first second (FEV1).

The incidence of PPCs and the length of postoperative stay: - using the Melbourne Group Scale Dyspnea. According to the revised or modified Borg scale or rating of perceived exersion.

The Rand SF 36 health survey questionnaire. 2. For treatment The power lung device. Acapella device.

Eligibility criteria: Inclusion Criteria:

* They will be from 40-50 years old.
* They will be patients undergo elective CABG surgery.
* Non productive cough postoperatively.
* Cough pain intensity \> 5 as rated on a visual analogue scale (VAS) on postoperative day 1.

Exclusion Criteria:

* Patients with chronic chest diseases.
* Patients with an intensive postoperative care (ICU) stay \> 48 hrs.
* Uncooperative patients.

Primary outcomes:
measure: Arterial blood gases including:
timeFrame: One week
Secondary outcomes:
measure: Spirometry
timeFrame: One week
Other outcomes:
measure: Dyspnea
timeFrame: One week
measure: The incidence of postoperative pulmonary complications
timeFrame: One week
measure: Quality of life
timeFrame: One week
Locations:
city: Qinā
country: Egypt
facility: Shymaa yussuf abo zaid
Study officials:
affiliation: Assistant lecturer
name: Shymaa Y Abo zaid, Master
role: PRINCIPAL_INVESTIGATOR
References: